Paclitaxel

nuclear factor kappa B subunit 1 ; Homo sapiens







80 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34992683 Paclitaxel resistance is mediated by NF-κB on mesenchymal primary breast cancer cells. 2022 Feb 5
2 35477477 High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer. 2022 Apr 27 1
3 33156701 lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway. 2021 Mar 1
4 34360846 Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells. 2021 Jul 28 1
5 34749510 Psoralen-loaded polymeric lipid nanoparticles combined with paclitaxel for the treatment of triple-negative breast cancer. 2021 Nov 1
6 32401925 Treatment with β-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-κB pathway. 2020 2
7 32447047 Administration with hyperoside sensitizes breast cancer cells to paclitaxel by blocking the TLR4 signaling. 2020 Oct 1
8 32547883 Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways. 2020 2
9 32594651 Paclitaxel induces apoptosis through the TAK1-JNK activation pathway. 2020 Aug 1
10 32848392 CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. 2020 1
11 33087151 Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway. 2020 Oct 21 1
12 31660072 CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50. 2019 2
13 28771725 TLR4 and NFκB signaling is critical for taxol resistance in ovarian carcinoma cells. 2018 Mar 6
14 29567488 Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells. 2018 Jun 2
15 29643394 Author Correction: Kanglaite sensitizes colorectal cancer cells to Taxol via NF-κΒ inhibition and connexin 43 upregulation. 2018 Apr 12 1
16 30355931 Effect of Paclitaxel+Hirudin on the TLR4-MyD88 Signaling Pathway During Inflammatory Activation of Human Coronary Artery Smooth Muscle Cells and Mechanistic Analysis. 2018 4
17 30505814 Naringin sensitizes human prostate cancer cells to paclitaxel therapy. 2018 Dec 1
18 28260091 Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. 2017 Apr 7
19 28440494 Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer. 2017 Jun 2
20 28541685 Discovery of 1,4-Benzodiazepine-2,5-dione (BZD) Derivatives as Dual Nucleotide Binding Oligomerization Domain Containing 1/2 (NOD1/NOD2) Antagonists Sensitizing Paclitaxel (PTX) To Suppress Lewis Lung Carcinoma (LLC) Growth in Vivo. 2017 Jun 22 1
21 26531258 Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes. 2016 Jan 2
22 26596839 Increased expression of MyD88 and association with paclitaxel resistance in breast cancer. 2016 May 1
23 26842845 Profilin potentiates chemotherapeutic agents mediated cell death via suppression of NF-κB and upregulation of p53. 2016 Apr 1
24 25499080 Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells. 2015 Feb 28 1
25 25681684 Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells. 2015 Apr 6
26 25791937 Enhanced cell growth inhibition by thiacremonone in paclitaxel-treated lung cancer cells. 2015 Jul 1
27 26108226 Paclitaxel-sensitization enhanced by curcumin involves down-regulation of nuclear factor-κB and Lin28 in Hep3B cells. 2015 2
28 26463651 Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone. 2015 Nov 7
29 26502701 INHIBITOR OF THE TRANSCRIPTION FACTOR NF-κB, DHMEQ, ENHANCES THE EFFECT OF PACLITAXEL ON CELLS OF ANAPLASTIC THYROID CARCINOMA IN VITRO AND IN VIVO. 2015 May-Jun 6
30 24462773 CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells. 2014 May 2
31 24520227 Synergistic Effect of COX-2 Inhibitor on Paclitaxel-Induced Apoptosis in the Human Ovarian Cancer Cell Line OVCAR-3. 2014 Jan 2
32 24566868 RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance. 2014 Apr 15 3
33 25230791 Paclitaxel in combination with cetuximab exerts antitumor effect by suppressing NF-κB activity in human oral squamous cell carcinoma cell lines. 2014 Dec 2
34 25550688 Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells. 2014 3
35 23380587 Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clusters. 2013 Apr 1
36 23500524 ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel. 2013 Jun 1
37 23708960 CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-κB regulation in breast cancer cells. 2013 Oct 1
38 22754361 Protective effect of caffeic acid on paclitaxel induced anti-proliferation and apoptosis of lung cancer cells involves NF-κB pathway. 2012 2
39 22993037 Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo. 2012 Dec 2
40 23027625 Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway. 2012 Dec 3
41 23155247 Desensitization of NFκB for overcoming chemoresistance of pancreatic cancer cells to TNF-α or paclitaxel. 2012 Nov 2
42 23170132 Effect of NF-κB inhibitors on the chemotherapy-induced apoptosis of the colon cancer cell line HT-29. 2012 Oct 1
43 20883815 Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. 2011 Mar 8
44 21223991 Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. 2011 Apr 1
45 21289336 Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. 2011 Jan-Feb 1
46 21844414 The effect of indomethacin on paclitaxel sensitivity and apoptosis in oral squamous carcinoma cells: the role of nuclear factor-κB inhibition. 2011 Aug 7
47 19824995 Vitamin E succinate induced apoptosis and enhanced chemosensitivity to paclitaxel in human bladder cancer cells in vitro and in vivo. 2010 Jan 2
48 19908232 Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NF-kappaB using ursolic acid. 2010 Jul 15 1
49 19278222 Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. 2009 May-Jun 2
50 19461204 The role of Bcl-xL and nuclear factor-kappaB in the effect of taxol on the viability of dendritic cells. 2009 Jun 2